These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Promises and Challenges of Smac Mimetics as Cancer Therapeutics. Fulda S Clin Cancer Res; 2015 Nov; 21(22):5030-6. PubMed ID: 26567362 [TBL] [Abstract][Full Text] [Related]
3. Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy. Zhao XY; Wang XY; Wei QY; Xu YM; Lau ATY Cells; 2020 Apr; 9(4):. PubMed ID: 32325691 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways. Derakhshan A; Chen Z; Van Waes C Clin Cancer Res; 2017 Mar; 23(6):1379-1387. PubMed ID: 28039268 [TBL] [Abstract][Full Text] [Related]
5. Small-molecule SMAC mimetics as new cancer therapeutics. Bai L; Smith DC; Wang S Pharmacol Ther; 2014 Oct; 144(1):82-95. PubMed ID: 24841289 [TBL] [Abstract][Full Text] [Related]
6. Design of small-molecule Smac mimetics as IAP antagonists. Wang S Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport. Talbott RL; Borzilleri RM; Chaudhry C; Fargnoli J; Shen H; Fairchild C; Barnhart B; Ortega M; McDonagh TE; Vuppugalla R; Vite GD; Hunt JT; Gottardis M; Naglich JG Exp Cell Res; 2015 Nov; 338(2):251-60. PubMed ID: 26302264 [TBL] [Abstract][Full Text] [Related]
8. Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition. Wilkinson JC; Wilkinson AS; Scott FL; Csomos RA; Salvesen GS; Duckett CS J Biol Chem; 2004 Dec; 279(49):51082-90. PubMed ID: 15371416 [TBL] [Abstract][Full Text] [Related]
9. Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer. Nikkhoo A; Rostami N; Hojjat-Farsangi M; Azizi G; Yousefi B; Ghalamfarsa G; Jadidi-Niaragh F J Cell Biochem; 2019 Jun; 120(6):9300-9314. PubMed ID: 30506843 [TBL] [Abstract][Full Text] [Related]
10. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development. Ali R; Singh S; Haq W Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750 [TBL] [Abstract][Full Text] [Related]
11. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression. Santhanam M; Kumar Pandey S; Shteinfer-Kuzmine A; Paul A; Abusiam N; Zalk R; Shoshan-Barmatz V Mol Ther; 2024 Jun; 32(6):1934-1955. PubMed ID: 38582961 [TBL] [Abstract][Full Text] [Related]
12. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Bockbrader KM; Tan M; Sun Y Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155 [TBL] [Abstract][Full Text] [Related]
13. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins. Zhu H; Li Y; Liu Y; Han B ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274 [TBL] [Abstract][Full Text] [Related]
14. Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma. Wu MS; Wang GF; Zhao ZQ; Liang Y; Wang HB; Wu MY; Min P; Chen LZ; Feng QS; Bei JX; Zeng YX; Yang D Mol Cancer Ther; 2013 Sep; 12(9):1728-37. PubMed ID: 23699656 [TBL] [Abstract][Full Text] [Related]
15. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO). Ng CP; Bonavida B Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428 [TBL] [Abstract][Full Text] [Related]
16. SMAC Mimetics for the Treatment of Lung Carcinoma: Present Development and Future Prospects. Pandey R; Bisht P; Wal P; Murti K; Ravichandiran V; Kumar N Mini Rev Med Chem; 2024; 24(14):1334-1352. PubMed ID: 38275029 [TBL] [Abstract][Full Text] [Related]
17. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs). Rathore R; McCallum JE; Varghese E; Florea AM; Büsselberg D Apoptosis; 2017 Jul; 22(7):898-919. PubMed ID: 28424988 [TBL] [Abstract][Full Text] [Related]
18. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs. Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105 [TBL] [Abstract][Full Text] [Related]
19. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312 [TBL] [Abstract][Full Text] [Related]